Multiple Myeloma Immunotherapy Resistance: UCalgary Study | AcademicJobs
Explore the groundbreaking University of Calgary study revealing resistance mechanisms to GPRC5D immunotherapy in multiple myeloma, using Canada's largest relapsed patient cohort. Implications for future treatments.
higher-education-researchresearch-publication-newsprecision-oncology

